Chou; Chuan-Chu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chou; Chuan-Chu.The latest application filed is for "antibodies and variants thereof against pd-l1".

Company Profile

8.12.16

Chou; Chuan-Chu - Westfield NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Multispecific antigen binding proteins and methods of use thereof Grant 11,447,573 - Chou , et al. September 20, 2	2022-09-20
Antibodies And Variants Thereof Against Pd-l1 App 20220135687 - Yang; Shuai ; et al.	2022-05-05
Compositions And Methods For Increasing Protein Half-life In A Serum App 20220033481 - ZHANG; Yafeng ; et al.	2022-02-03
Chimeric Antigen Receptors Based On Single-domain Antibodies And Methods Of Use Thereof App 20210261675 - FAN; Xiaohu ; et al.	2021-08-26
Single-domain Antibodies And Variants Thereof Against Pd-l1 App 20210221891 - ZHANG; Yafeng ; et al.	2021-07-22
Anti-cd47 Antibodies That Do Not Cause Significant Red Blood Cell Agllutination App 20210070855 - Zhao; Tao ; et al.	2021-03-11
Chimeric antigen receptors based on single domain antibodies and methods of use thereof Grant 10,934,363 - Fan , et al. March 2, 2	2021-03-02
Single-domain Antibodies And Variants Thereof Against Tigit App 20210054071 - ZHANG; Wang ; et al.	2021-02-25
Single-domain Antibodies Against Lag-3 And Uses Thereof App 20210017279 - Zhang; Wang ; et al.	2021-01-21
Multispecific Antigen Binding Proteins And Methods Of Use Thereof App 20200369770 - ZHANG; Yafeng ; et al.	2020-11-26
Single-domain Antibodies And Variants Thereof Against Pd-1 App 20200347135 - ZHANG; Yafeng ; et al.	2020-11-05
Single-domain Antibodies And Variants Thereof Against Ctla-4 App 20190233519 - ZHANG; Yafeng ; et al.	2019-08-01
Multispecific Antigen Binding Proteins And Methods Of Use Thereof App 20190202935 - CHOU; Chuan-Chu ; et al.	2019-07-04
Chimeric Antigen Receptors Based On Single-domain Antibodies And Methods Of Use Thereof App 20180230225 - FAN; Xiaohu ; et al.	2018-08-16
MCP1-Ig fusion variants Grant 8,524,217 - Presta , et al. September 3, 2	2013-09-03
Method for treating atherosclerosis by administering human MCP1 fusions Grant 8,282,914 - Chou , et al. October 9, 2	2012-10-09
MCP1-Ig FUSION VARIANTS App 20110280873 - Presta; Leonard G. ; et al.	2011-11-17
Mcp1 Fusions App 20110206669 - Chou; Chuan-Chu ; et al.	2011-08-25
Methods for treating rheumatoid arthritis and multiple sclerosis using MCP1 fusions Grant 7,972,591 - Chou , et al. July 5, 2	2011-07-05
Mcp1 Fusions App 20100172904 - Chou; Chuan-Chu ; et al.	2010-07-08
MCP1 fusions Grant 7,713,521 - Chou , et al. May 11, 2	2010-05-11
MCP1 fusions App 20070036750 - Chou; Chuan-Chu ; et al.	2007-02-15
Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 Grant 6,451,982 - Chou , et al. September 17, 2	2002-09-17
Mammalian receptors for interleukin-10 Grant 6,423,500 - Moore , et al. July 23, 2	2002-07-23
Humanized monoclonal antibodies against human interleukin-5 Grant 6,056,957 - Chou , et al. May 2, 2	2000-05-02
Antibodies which specifically bind mammalian receptors for interleukin-10 (IL-10) Grant 5,863,796 - Moore , et al. January 26, 1	1999-01-26
Mammalian receptors for interleukin-10 (IL-10) Grant 5,789,192 - Moore , et al. August 4, 1	1998-08-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.